107
Views
2
CrossRef citations to date
0
Altmetric
ArticlesResearch

Insulin-dependent rescue from cardiogenic shock is not mediated by phospholamban phosphorylation

, , , &
Pages 296-302 | Received 17 Dec 2008, Accepted 04 Mar 2009, Published online: 06 May 2009
 

Abstract

Introduction. We used immunoblots to determine whether inotropic and lusitropic effects of high-dose insulin (HDI) in cardiogenic shock, induced by a β-blocker (BB) or a calcium channel blocker (CCB), are mediated by phosphorylation of phospholamban (PLB). PLB is a membrane protein that regulates calcium uptake into the sarcoplasmic reticulum (SR) by inhibition of the cardiac calcium pump (SERCA2a). Phosphorylation of PLB relieves SERCA inhibition, thus enhancing diastolic relaxation and preload. Methods. Our Institutional Animal Care and Use Committee approved this research. Swine myocardia from six groups were flash frozen immediately upon death or sacrifice. Groups 1–6 received: (1) no medications, (2) HDI and glucose only, (3) toxic propranolol infusions and saline resuscitation, (4) toxic propranolol infusions and HDI resuscitation, (5) toxic verapamil infusions and saline resuscitation, and (6) toxic verapamil infusions and HDI resuscitation. Groups 3–6 were resuscitated for 4 h. Tissue samples from all six groups were analyzed by quantitative immunoblots, using antibodies to both unphosphorylated PLB (uPLB) and phosphorylated PLB (pPLB), to determine the total PLB content and the fraction of PLB phosphorylated. Results. There were no differences in either pPLB or total PLB in cardiac tissue among any of the six groups. However, infusion of a pig with the β-adrenergic agonist, isoproterenol, produced enhanced PLB phosphorylation. Conclusion. The mechanism by which HDI produces its inotropic and lusitropic effects in CCB- and BB-induced cardiovascular toxicity, resulting in resuscitation, is not due to changes in phosphorylation of PLB or a change in the total PLB in the SR.

Acknowledgments

This work was supported in part by grants to DDT (NIH GM27906), NAA (NIH HL090074), and JH (HealthPartners Research Foundation 06-032). We thank Christine Karim for providing synthetic PLB standards and Octavian Cornea for assistance with manuscript preparation.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.